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Individual microRNAs (miRNAs) display distinct mRNA targeting
“rules”
Wang-Xia Wang, Bernard R. Wilfred, Kevin Xie, Mary H. Jennings, Yanling Hu, Arnold J.
Stromberg, and Peter T. Nelson*
Department of Pathology and Division of Neuropathology; University of Kentucky Medical Center
and Sanders-Brown Center on Aging; University of Kentucky; Lexington, KY USA
Abstract
MicroRNAs (miRNAs) guide Argonaute (AGO)-containing microribonucleoprotein (miRNP)
complexes to target mRNAs. It has been assumed that miRNAs behave similarly to each other
with regard to mRNA target recognition. The usual assumptions, which are based on prior studies,
are that miRNAs target preferentially sequences in the 3′UTR of mRNAs, guided by the 5′ “seed”
portion of the miRNAs. Here we isolated AGO- and miRNA-containing miRNPs from human H4
tumor cells by co-immunoprecipitation (co-IP) with anti-AGO antibody. Cells were transfected
with miR-107, miR-124, miR-128, miR-320, or a negative control miRNA. Co-IPed RNAs were
subjected to downstream high-density Affymetrix Human Gene 1.0 ST microarray analyses using
an assay we validated previously—a “RIP-Chip” experimental design. RIP-Chip data provided a
list of mRNAs recruited into the AGO-miRNP in correlation to each miRNA. These
experimentally identified miRNA targets were analyzed for complementary six nucleotide “seed”
sequences within the transfected miRNAs. We found that miR-124 targets tended to have
sequences in the 3′UTR that would be recognized by the 5′ seed of miR-124, as described in
previous studies. By contrast, miR-107 targets tended to have ‘seed’ sequences in the mRNA open
reading frame, but not the 3′ UTR. Further, mRNA targets of miR-128 and miR-320 are less
enriched for 6-mer seed sequences in comparison to miR-107 and miR-124. In sum, our data
support the importance of the 5′ seed in determining binding characteristics for some miRNAs;
however, the “binding rules” are complex, and individual miRNAs can have distinct sequence
determinants that lead to mRNA targeting.
Introduction
MicroRNAs (miRNAs) regulate gene expression of their target mRNAs through many
different mechanisms. These mechanisms including inhibition of translation at initiation
and/or post-initiation, deadenylation, nucleolysis and others.1–5 Argonaute (AGO) proteins,
which bind directly to mature miRNAs, are a central component of most mammalian
microribonucleoparticles (miRNPs).1,6–8 As miRNAs regulate gene expression through
differing mechanisms, and most of those mechanisms seem to still involve AGO-miRNPs,
there must be differing subtypes of miRNPs that subserve somewhat different functions. To
date, the full variety of miRNP subytpes and miRNA-related mechanisms have not been
completely elucidated.
In addition to the complexity of miRNA mechanisms, researchers are challenged with
predicting exactly which miRNAs will bind to which individual mRNA targets. This is a
formidable task because metazoan miRNAs tend to bind to mRNA targets through partial
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sequence complementarity. Much has been learned about the principles that govern those
interactions, relating to the complementary sequence determinants between miRNAs and
target mRNAs. Computational algorithms, based on prior experimental studies, can help to
predict mRNA target binding.9–13 However, the biochemistry underlying miRNA:mRNA
interactions still needs to be fully elucidated.
The two issues described above—different miRNA functional mechanisms on the one hand,
and the sequence determinants of miRNA:mRNA targeting principles on the other—may be
linked. The sequence determinants for mRNA targeting according to one mechanism may
not be identical to that for another mechanism across all species and cell types. In order to
better understand and test these complex ideas, more experiments are required that involve
direct determination of miRNA targets.
A promising method for directly characterizing miRNPs is co-immunoprecipitation (co-IP)
that pulls down AGO proteins along with associated molecules.7,14 Using AGO co-IP
assays, researchers have isolated multiple proteins, miRNAs, and mRNA targets from
miRNPs.15–21 A subset of AGO co-IP experiments involve “RIP-Chip”22,23 techniques that
integrate miRNP co-IP with downstream high-density microarrays to study target mRNAs
systematically.
Here we describe results using a RIP-Chip assay that uses Anti-AGO to co-IP mRNA
targets. The monoclonal antibody (“Anti-AGO”, which was also termed “2A8”) was raised
against human AGO2, and recognizes a C-terminal epitope on AGO2.24 Multiple human
and mouse AGO paralogs are also recognized by Anti-AGO, both in co-IPs and on western
blots. Here, the co-IP was coupled with downstream high-throughput microarray analyses of
mRNAs that are associated with miRNPs. Applying this method to H4 glioneuronal cell
line25 enabled us to evaluate some of the sequence determinants of miRNA:mRNA
interactions.23 The RIP-Chip experimental assay, coupled with computational analyses,
were used to provide new information about miRNA targeting.
Results
The study design is indicated schematically in Figure 1. The putative miRNA targets
(PmiTs) were experimentally identified by applying a threshold of least two-fold enriched in
the co-IPed miRNPs following the transfection of individual miRNAs. The results of three
biological replicates were used in each case. Less-enriched targets, or targets that exhibited
decreased levels in the lysates, were not included in this study. A list of PmiTs identified
with RIP-Chip is shown in Table 1. Note that miR-320 had the most PmiTs identified (57
total), relative to the other miRNAs studied. Several PmiTs in this list have been validated
previously.23
PmiTs identified using the RIP-Chip assay served as the bases to analyze some of the
sequence determinants that are correlated with miRNA targeting in these cultured cells. As
shown in Figure 1B, the mRNA sequences of the PmiTs were evaluated for the presence of
6mer sequences that were antisense complementary to portions of the transfected miRNAs.
Sequences across the full length of the miRNAs were evaluated; for example, 18 different
6mers were studied in the case of miR-107. Complementary sites in the sequences of the
5′UTRs, open reading frames, and 3′UTRs were searched separately. Thus we could test
hypotheses about how miRNAs target mRNAs in terms of the 6mer sequences in different
portions of the miRNAs and mRNAs.
For miR-124, there was a clear and strong tendency for sequences complementary to the 5′
seed (nts #2–7) of miR-124 to be present in the 3′UTR of PmiTs. For example, the 6mer
seed complementary to miR-124 nts #2–7 was present, on average, once per 410 nts in the 3′
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UTR of miR-124 PmiTs, in contrast to once per 1,604 nts in the 3′ UTR of miR-107 PmiTs.
See Table 2 for specific information about miR-124 seed sequences in PmiTs. Statistical
analyses were performed using the Fisher’s exact test to evaluate the likelihood that these
sequence elements would have been present in the PmiTs by chance (Fig. 2). These data are
presented using a chart with the −log(p value) on the Y axis to demonstrate the tendency for
the sequences complementary to corresponding 6mers on the miR-NAs to be present in
5′UTR, open reading frame, and 3′UTR of PmiTs. Note that the p values for 5′ seeds starting
at nts #1, #2 and #3 were significant at the level of p < 10−6, p < 10−12 and p < 10−4,
respectively. By contrast, there was no indication of tendency for miR-124 complementary
6mer sequences to be present in the 5′ UTR or open reading frame of mRNAs that were
miR-124 PmiTs.
Figure 3 shows that the mRNAs identified as miR-320 and miR-128 PmiTs also showed
significant enrichment for 5′ seed sequences for their respective miRNAs within the 3′UTRs,
again as assessed using the Fisher’s exact test. However, these miRNAs’ PmiTs did not have
the same degree of enrichment as seen in miR-124 PmiTs. Whereas the enrichment was
significant to p < 10−12 for miR-124, the significance was at p < 10−4 for miR-128 and p <
10−3 for miR-320. Note that for both miR-128 and miR-320 there were 3′ miRNA seed
regions, corresponding in antisense orientation to nts #11–14, with lower p values (~p <
0.01), indicating a possible contributory binding via 3′ sequences on the miRNAs.
The results for miR-107 were quite different in comparison to those of miR-124, miR-128 or
miR-320. For miR-107 there was a marked tendency for the miR-107 6mer complementary
seed sequences to be present in the PmiTs’ open reading frames (Table 2). Also represented
in Figure 4, it was the 5′ seed (nts #2–7) that was by far the strongest associational
determinant of this binding (p < 10−11). Remarkably, there was no enrichment among
miR-107 PmiTs for 6-mer 3′UTR sequences corresponding to miR-107.
Figure 5 provides a schematic/cartoon depiction of representative PmiTs for miR-107 in
contrast to miR-124. PTBP1 is chosen as representative for miR-124 target because it was
identified in the current RIP-Chip assay and has also been shown previously to be a
validated miR-124 target.26 As miR-107 PmiTs for this figure, we chose GRN, PPIB,
INSIG1 and RPLP0 as being representative. GRN is the strongest target identified using
RIP-Chip in H4 cells and is the topic of a separate paper (Wang W-X, et al. In Press). For
Figure 5 we included ‘seed’ sequences separately that would pair through G-U bindings
(blue triangles), in addition to the “canonical”, but completely separate, G-C binding (red
triangles).
Immunoblots of GRN, INSIG1 and PPIB were performed after miRNA transfections to
assess whether the surprising miR-107 RIP-Chip results were truly indicating physiological
miR-107 targets. Transfections were performed with both miR-107 and with the negative
control miRNA (Fig. 6). All of the assessed miR-107 PmiTs (but not the control, beta-Actin)
were indeed knocked down following miR-107 transfection.
To provide some idea of signal-to-noise ratio for the RIP-Chip assay, we assessed the
presence of “sense-oriented” 6mer sequences (see Fig. 1B) in the PmiTs. These sequences
would not be predicted to be recognized by their respective miRNAs, so they serve in this
context as control sequences. Data from these analyses are shown in Figure 7 which again
depict the −log(p value) from multiple Fisher’s exact tests. Note that the p values indicate a
much less significant enrichment in these cases than for the 6mer sequences in the antisense
orientation, which suggest that the results for the “antisense”-oriented 6mer seeds are
specific.
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Luciferase reporter assays were employed to demonstrate that a specific sequence in the
open reading frame INSIG1 could be specifically targeted by miR-107. We cloned a
segment of INSIG1 open reading sequence (nts 370–518) that contains two TGCTGC
iterations (INSIGMRE), and its mutated counterpart (INSIGMREmut, see Fig. 8) in pRL-
TK reporter plasmid. Co-transfection of reporter plasmids and miRNAs demonstrated that
INSIGMRE reporter, but not its mutant, was effectively knock-downed by miR-107,
indicating the specificity of miR-107 targeting on the seed sequence in INSIG1 mRNA.
Similar reports were obtained for reporter assays referent to a GRN mRNA open reading
frame sequence (Wang W-X, et al. In Press).
Discussion
RIP-Chip experiments show that the mRNAs targeted by individual miRNAs may be
recruited according to distinct sequence determinants. In line with prior studies, our data
analyses confirm that miRNA 5′ seeds12,27 are critical determinants with target sites usually
in the 3′UTRs of PmiTs for miR-124, miR-128 and miR-320. As has also been shown
previously,28 there are 3′ seed sequences in miRNAs that also appear to contribute to target
binding, and sites outside the 3′UTR where miRNA seeds are found in PmiTs. Most notably,
in our current study, miR-107 appears far more likely than other tested miRNAs to target the
open reading frame of mRNAs. In contrast, miR-107 complementary 6mer seeds are
remarkably less enriched in the 3′UTR of miR-107 PmiTs. Immunoblot analyses and
reporter assays provide further validation of the miR-107 targets. Together these data
demonstrate the importance of evaluating individual miRNAs experimentally instead of
relying solely on a universal prediction algorithm.
Prior studies have shown that the open reading frame of mRNAs can be targeted by
miRNAs. For example, the genes Nanog, Oct4, Sox2 and Dicer are regulated through
miRNA targeting in their mRNAs’ open reading frames.28,29 In high-throughput, direct
experimental evaluation of miRNA target with “HITS-CLIP” in mouse brain, some 25% of
miRNA target sequences resided in open reading frames of targeted mRNA.30 Further, it has
been known for years that small interfering RNAs target open reading frame of mRNAs
using the same or very similar molecular machinery.31 A recent review summarizes
evidence that a miRNA may recognize target mRNAs’ open reading frames.28 However, it
has not been shown previously that a given miRNA—such as miR-107—tend to target
mRNAs selectively in the open reading frame.
If there are idiosyncratic determinants of specific miRNA and mRNA targets, there must be
corresponding biological explanations. The differences in targeting characteristics between
miRNAs may be due to individual miRNAs existing in differing cell compartments. Some
miRNAs are spatially trafficked specifically to particular parts of the cell (nucleus versus
cytoplasm, and dendrites versus axons, for example) and these compartmental differences
might be accompanied by differing target determinants.32–36 Alternatively, particular
miRNAs may interact selectively with different proteins—miRNAs comprise only a small
portion of miRNPs and AGO is only one of the many miRNP-associated proteins.7,8,21,37
MiR-107 has been shown to share an unusual sequence motif with the miRNA let-7.
Through this motif, miR-107 may interact with mRNA targets through a novel mechanism
associated with the uridylyl transferase protein “TUTase 4” (TUT4).38 In future studies,
some distinct characteristics of miR-107 may be linked to this interaction.
There are limitations to the current study. H4 “neuroglioma” cells derive from an aneuploid
cancer cell line comprising an imperfect model of any particular “normal” cell.25 We have
shown previously that the miRNP is functional in H4 cells23 but there may be currently
uncharacterized idiosyncrasies. Aside from the inherent limitations of the cultured tumor
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cells, RIP-Chip is an assay that does not provide all the information about miRNA:mRNA
interactions. AGO-miRNPs have been shown to exert gene expression regulation via
multiple mechanisms.1,3 For the mRNA target to be detected by a microarray downstream
of the anti-Ago co-IP, the target mRNA must be stably bound to the miRNP. This may not
necessarily be the case if the miRNA:mRNA interaction is transient or if the main
mechanism for the translational inhibition involves mRNA degradation. In other words, our
experimental design probably only describes a subset of miRNA:mRNA interactions.
In summary, analyses of RIP-Chip experiments in H4 cells suggest that individual miRNAs
bind to target mRNA using different sequence determinants. Future studies may help
explore how and why such short RNA molecules can exhibit distinct binding tendencies. In
addition, these data also indicate the need for more “cross-talk” between high-throughput
experimental studies and computational algorithms used to predict miRNA targets.
Materials and Methods
Co-IP of miRNPs using anti-AGO antibodies
The Anti-AGO RIP-Chip methodology has been validated and described in detail.23 Briefly,
Protein G agarose beads (Invitrogen, Carlsbad, CA) were incubated with monoclonal anti-
AGO.24 Beads were washed 3 times in PBS and twice in lysis buffer (25 mM Tris-HCl, pH
8.0, 150 mM NaCl, 2 mM MgCl2, 0.5% NP-40 and 5 mM DTT). 48 hours after the final
transfection(s), the cells were rinsed twice in PBS, then lysed on ice for 10 minutes in fresh
lysis buffer with protease inhibitors (1 tablet/10 ml lysis buffer, Complete Protease Inhibitor
Cocktail Tablets, EDTA-free, Roche Applied Science, Mannheim, Germany) and RNasin
(250 U/ml; Promega, Madison, WI). Lysates were precleared with pre-blocked Protein G
beads at 4°C for 60 min and then co-IP was performed with 2A8,24-Protein G beads at 4°C
for 90 min. After co-IP, the beads were washed twice with lysis buffer; three times with
lysis buffer containing 900 mM NaCl and 1% NP-40; twice more with lysis buffer, followed
by a final wash with lysis buffer containing 0.05% NP-40. Beads were then incubated with
250 μl of DNA digestion solution (40 mM Tris-HCl, pH 8.0, 10 mM MgSO4, 1 mM CaCl2,
200 U/ml RNasin, and 40 U/ml DNase I (Promega, Madison, WI)) at 37°C for 20 min with
shaking. RNA was extracted using Trizol LS (Invitrogen, Carlsbad, CA) as described.39
Microarray analysis and RT-qPCR
Microarray analysis of RNAs isolated from co-IP or from total lysates were performed using
Affymetrix Human Gene 1.0 ST™ chip at University of Kentucky Microarray Core Facility.
Three biological replicates were carried out in each treatment.
Downstream data analyses
Criteria for selecting PmiTs according to our anti-AGO RIP-Chip data (based on the
averaged results of the three biological replicates on the array data for each transfection
condition) were as follows:
1. The mRNA was enriched more than two-fold higher in the AGO-miRNPs after the
cells were transfected with a particular miRNA, relative to negative control
miRNA; and
2. The same mRNA was not upregulated more than two-fold in the lysate after
transfection with the miRNA.
Following the identification of PmiTs using these criteria, the 5′UTR, open reading frame,
and 3′UTR sequences were analyzed for 6-mer sequences correlating to portions of the miR-
NAs (in antisense and sense orientation). The total number of complementary sequences in
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each location was assessed using the Fisher’s exact test to determine whether this number
would be expected to occur by chance.
Immunoblot analysis of miRNA targets
RIP-Chip experiments identified miR-107 PmiTs with miR-107 binding elements in the
open reading frames. A subset of these targets were subjected to further biochemical
validation. Full-length cDNA plasmid that express human granulin (GRN, NM_002087.2),
and insulin induced gene 1 (INSIG1, NM_005542.3) were purchased from OriGene
(OriGene Technologies, Inc., Rockville, MD). H4 cells were first transfected with either
GRN, or INSIG1, or empty vector plasmids for 24 hr using LF-2000 (Invitrogen, Carlsbad,
CA); and were then transfected with 25 nM of Pre-miR-107 or “Pre-miR negative control
#1” (Ambion, Austin, TX) for additional 48 hr. For GRN and PPIB analysis, total soluble
protein was isolated and used for immunoblot analysis; For INSIG1, membrane proteins
were isolated and used in western blot analysis. Goat anti-human GRN antibody (R&D
systems, Minneapolis, MN); rabbit anti-human INSIG1, mouse anti-human PPIB (Santa
Cruz Biotechnology, Santa Cruz, CA); rabbit anti-β-Actin antibody (Rockland, Gilbertsville,
PA) were used at 1:500, 1:200, 1:2,000 and 1:4,000, respectively.
Reporter assays of INSIG1 mRNA putative miR-107 target sites
To test whether a sequence (nts 370–518) in INSIG1 mRNA open reading frame that
contains two antisense miR-107 seed sequences are miR-107 target sites, we constructed
pRL-TK reporters bearing either the original sequence (designed as INSIGMRE), or its
mutated sequence (designed as INSIGMREmut), where the seed region was altered.
Reporter assay procedure was described in detail previously.39 Briefly, pRL-TK reporter
plasmids (INSIGMRE and INSIGMREmut) along with a control reporter plasmid pGL3
were first transfected in H4 cells. Transfected cells were washed in antibiotic-free media
after 6 hr of transfection, and the cells were allowed to recover overnight. Twenty-four
hours after the first transfection, cells were further transfected with 25 nM of Pre-miR-107,
Pre-miR-320, or a negative control for Pre-miRNAs (Ambion). Luciferase reporter activity
was measured 48 hr after the Pre-miRNA transfection. Each transfection was performed in
triplicate and data shown represent two individual experiments.
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Figure 1.
(A) Experimental design. Following miRNA transfections (performed with three biological
replicates), Anti-AGO RIP-Chip was performed. Analyses of Affymetrix Human Gene 1.0
ST microarray data were used to identify mRNA targets enriched following miRNA
transfections. (B) Further analyses were performed on putative miRNA targets (PmiTs). The
5′ UTR, open reading frames, and 3′ UTR of PmiTs were evaluated for ‘seed’ sequences
corresponding to the complementary 6mers from different portions of transfected miRNAs.
For example, “seed 1” for miR-107 corresponds to the 6 nucleotides at the 5′ end of
miR-107, whereas “seed 18” corresponds to the 6 nucleotides at the 3′ end of miR-107. Most
experiments were performed using the “anti-sense” seeds as shown, but for control
experiments, “sense” sequences were evaluated.
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Figure 2.
As has been shown previously, miR-124 targets tend to have “seed” sequences
corresponding to nucleotides #2–7 in miR-124, specifically in the 3′ UTR. This chart shows
the −log(p value) of Fisher’s exact test analyses to determine the likelihood that the number
of sequences found in the putative miRNA targets would have occurred by chance. Separate
analyses were performed for the 5′ UTR, open reading frame (“Coding”), and 3′ UTR. Note
that the 5′ seeds (6mer sequences corresponding to #1–6, #2–7 and #3–8) of miR-124 are
enriched in miR-124 putative miRNA targets, but only in the 3′ UTR.
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Figure 3.
As was the case for miR-124, putative miR-128 and miR-320 putative targets tend to have
sequences corresponding to nucleotides #2–7 in the 3′UTR. However, the tendency for these
two miRNAs is much less strong (p < 10−5 versus p < 10−11). Moreover, unlike miR-124,
both miR-128 and miR-320 have a tendency—albeit far weaker than the 5′ seed—for the 3′
sequences of the miRNAs to have possible effects (enrichment of complementary 6mers in
putative targets). Since the current study was limited to studying 6mer seeds, these data do
not test whether sequence determinants with fewer hybridizing nucleotides (5mers and
smaller) may be more important in the case of these other miRNAs.
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Figure 4.
(A) Unlike for miR-124 and the other miRNAs tested in the current study, putative miR-107
targets have a marked tendency to have “seed” sequences corresponding to miR-107
nucleotides #2–7 in the open reading frame (“Coding” sequence) as opposed to the 3′ UTR.
Equally remarkable is the apparent lack of a tendency for miR-107 seed sequences to be
enriched in the 3′ UTR of miR-107 targets identified experimentally using anti-AGO RIP-
Chip. (B) To evaluate whether miR-107 seed sequences are present in other mRNAs (i.e.,
nonspecifically), we tested other groups of mRNAs and such was not the case. For example,
we sampled those mRNAs that were recruited into the AGO-miRNP according to anti-AGO
RIP-Chip after miR-124 transfection. There is no “nonspecific” tendency for miR-107
nucleotides #2–7 (in antisense) to be present in these or other mRNAs that were analyzed.
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Figure 5.
A cartoon to demonstrate that mRNAs strongly recruited into the AGO-
microribonucleoparticle following transfection with miR-107 tended to have “seed”
sequences corresponding to miR-107 nucleotides #2–7 in the open reading frame. miR-124
‘seed’ sequences on the PTBP1 are shown at top because this gene has been shown
previously to be a miR-124 target and it was a strong miR-124 target on the RIP-Chip assay.
Note that the seed sequences corresponding to miR-124 (in antisense) are present mostly
within the 3′ UTR of miR-124 targets. Even those miR-124 seed sequences that would rely
on G-U binding are mostly in the 3′UTR. By contrast, the miR-107 putative targets tend to
contain 5′ seed sequences of miR-107 in the open reading frame. Again, this tendency is also
seen for 6mers that would theoretically cause binding with the 5′ seed of miR-107 through
G-U binding.
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Figure 6.
The putative miR-107 targets identified experimentally by RIP-Chip were subjected to
biochemical validation. These proteins are GRN, INSIG1 and PPIB, which are targeted by
miR-107 in the open reading frame as shown in Figure 5. Immunoblot analyses of these
proteins’ expression following transfections of miR-107 (versus control miRNA) show that
the expression of these genes are effectively suppressed by miR-107. Beta-Actin
immunoblots following identical transfections provides a negative control.
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Figure 7.
Control experiments show that there is relatively low background “noise” in the anti-AGO
RIP-Chip results. These analyses were performed testing for the presence of 6mer sequences
corresponding to portions of miRNAs in the “sense” orientations that are predicted NOT to
bind to the mRNA targets. Shown here are the results for miR-320, which are representative.
As in Figures 2–4 and 7, the Y axis shows the results of −log(p value) for Fisher’s exact test
to assess the likelihood that the sequences occurred by chance.
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Figure 8.
Dual luciferase reporter assays were used to validate miR-107 target sites on INSIG1
mRNA. A sequence in the INSIG1 mRNA open reading frame (nts 370–518) that contains
two TGCTGC iterations (top) was subcloned into pRL-TK reporter plasmid (INSIGMRE).
The pRL-TK plasmid containing the mutated sequence of INSIGMRE (INSIGMREmut,
which is only subtly different as shown) was constructed in parallel. Plasmid transfection,
miRNA transfection, and dual luciferase activity assay were followed our published
protocols (See Methods section). The figure showed that INSIGMRE specifically responds
to miR-107 transfection but not to miR-320, or to a negative control miRNA. “*”-Student’s
one-tailed t-test p < 0.001.
Wang et al. Page 16
RNA Biol. Author manuscript; available in PMC 2011 May 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Wang et al. Page 17
Ta
bl
e 
1
Ta
rg
et
s i
de
nt
ifi
ed
 u
si
ng
 A
nt
i-A
G
O
 R
IP
-C
hi
p
m
iR
-1
07
m
iR
-1
24
m
iR
-1
28
m
iR
-1
20
G
R
N
PT
B
P1
LS
M
10
LS
M
2
N
R
N
1
C
TD
SP
1
IN
SI
G
1
A
PE
X
2
TX
N
IP
A
N
X
A
2P
2
A
P2
A
1
O
SR
2
R
PL
PO
SN
A
I2
D
B
I
A
R
PC
1A
TS
PA
N
13
LY
6E
C
22
or
f1
3
C
TD
SP
1
R
A
B
24
SE
PW
1
C
PS
F6
A
N
X
A
2P
1
ZD
H
H
C
4
LA
G
E3
C
D
H
11
M
T2
A
N
R
1H
2
SA
LL
1
SA
T1
A
TP
6V
O
E1
PA
R
S2
A
N
X
A
2
C
TF
8
PR
R
13
E 
I R
3I
P1
TM
EM
69
LD
LR
TR
A
PP
C
1
B
H
LH
B
2
U
B
A
52
PP
IB
SL
C
16
A
13
A
N
X
A
7
E2
F4
SR
F
Y
K
T6
R
PL
1O
ER
A
L1
R
PS
15
PG
K
1
TE
X
26
1
R
H
O
G
S1
00
A
10
FT
L
R
PL
41
ST
X
1O
M
T1
G
ST
U
B
1
TC
EA
2
N
M
E4
FA
M
12
7C
IT
FG
3
H
R
B
PP
A
P2
B
U
R
O
S
M
EA
1
D
U
LL
A
R
D
ZF
P3
6L
2
C
6o
rf
12
5
B
C
L7
B
TB
C
A
PC
O
LC
E
D
Y
N
LR
B
1
C
A
PN
S1
M
T2
A
U
FC
1
M
T2
A
PP
IL
1
SY
N
G
R
2
C
C
N
JL
FL
J2
04
89
SC
N
1B
C
SF
1
PP
IA
FA
M
89
A
R
N
A
SE
K
PR
R
13
C
C
L2
C
LD
N
12
PP
P1
R
11
Pu
ta
tiv
e 
m
iR
N
A
 ta
rg
et
s (
Pm
iT
s)
 fo
r m
iR
-1
07
, m
iR
-1
24
, m
iR
-1
28
 a
nd
 m
iR
-3
20
. T
he
se
 w
er
e 
se
le
ct
ed
 o
n 
th
e 
ba
si
s o
f b
ei
ng
 e
nr
ic
he
d 
m
or
e 
th
an
 tw
o-
fo
ld
 in
 th
e 
A
G
O
-m
iR
N
Ps
 fo
llo
w
in
g 
an
ti-
A
G
O
 R
IP
-C
hi
p.
RNA Biol. Author manuscript; available in PMC 2011 May 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Wang et al. Page 18
Table 2
Number of 5′ seed complementary sequences per 1,000 nts observed in 5′UTR, open reading frame (ORF), or
3′UTR of putative miRNA targets for miR-107, miR-128 and miR-320.
miR-107 5′ seed seqs/1,000 nts
PmiTs 5′UTR ORF 3′UTR
miR-107 1.50 4.63 0.51
miR-124 0.86 1.19 0.71
miR-128 1.64 0.59 0.10
miR-320 0.39 0.97 1.02
miR-124 5′ seed seqs/1,000 nts
PmiT’s 5′UTR ORF 3′UTR
miR-107 0.00 0.51 0.64
miR-124 0.58 0.65 2.32
miR-128 0.00 0.39 0.39
miR-320 0.10 0.40 1.02
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